418
Participants
Start Date
July 28, 2018
Primary Completion Date
August 23, 2023
Study Completion Date
August 23, 2023
ATG/PTCy
low dose Antithymocyte Globulin plus low dose post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation
standard ATG
in vivo T cell depletion (TCD) with anti-thymocyte globulin (ATG) as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation
standard PTCy
post-transplant cyclophosphamide (PTCy) as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell
Shanghai Ruijin Hospital, affiliated with the Medical School of Shanghai Jiaotong University,, Shanghai
Changhai Hospital, Shanghai
Xianmin Song, Shanghai
General Hospital of Jinan Military Command., Qinan
Shanghai Xinghua Hospital, affiliated with the Medical School of Shanghai Jiaotong University,, Shanghai
Shanghai tongji hospital, Shanghai
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
OTHER